Literature DB >> 11442300

Natural history of Alzheimer's disease.

L S Honig1, R Mayeux.   

Abstract

Alzheimer's disease (AD) is the principal cause of dementia in the elderly, and affects about 15 million people worldwide. The earliest symptom is usually an insidious impairment of memory. As the disease progresses, there is increasing impairment of language and other cognitive functions. Problems occur with naming and word-finding, and later with verbal and written comprehension and expression. Visuospatial, analytic and abstract reasoning abilities, judgment, and insight become affected. Behavioral changes may include delusions, hallucinations, irritability, agitation, verbal or physical aggression, wandering, and disinhibition. Ultimately, there is loss of self-hygiene, eating, dressing, and ambulatory abilities, and incontinence and motor dysfunction. Before diagnosis of AD, individuals may have memory complaints, which represent a period of mild cognitive impairment (MCI). Before MCI, there is a prodromal, ill-defined presymptomatic period of disease ('pre-MCI"). In this review, we particularly focus on these earliest stages. We also discuss the more advanced stages of AD, and address factors that may influence disease course. Understanding the natural history of AD will allow better targeting of the disease-modifying treatments that are on the horizon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442300     DOI: 10.1007/BF03351476

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  20 in total

Review 1.  The impact of mild cognitive impairment on functional abilities in the elderly.

Authors:  Steven M Albert; Matias H Tabert; Alan Dienstag; Gregory Pelton; Devangere Devanand
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 2.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

3.  Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.

Authors:  Elisa Canu; Donald G McLaren; Michele E Fitzgerald; Barbara B Bendlin; Giada Zoccatelli; Franco Alessandrini; Francesca B Pizzini; Giuseppe K Ricciardi; Alberto Beltramello; Sterling C Johnson; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

5.  Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease.

Authors:  Elisa Canu; Donald G McLaren; Michele E Fitzgerald; Barbara B Bendlin; Giada Zoccatelli; Franco Alessandrini; Francesca B Pizzini; Giuseppe K Ricciardi; Alberto Beltramello; Sterling C Johnson; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample.

Authors:  Rosa Rademakers; Marc Cruts; Kristel Sleegers; Bart Dermaut; Jessie Theuns; Yurii Aulchenko; Stefan Weckx; Tim De Pooter; Marleen Van den Broeck; Ellen Corsmit; Peter De Rijk; Jurgen Del-Favero; John van Swieten; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2005-08-30       Impact factor: 11.025

7.  Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study.

Authors:  Virginia G Wadley; Michael Crowe; Michael Marsiske; Sarah E Cook; Frederick W Unverzagt; Adrienne L Rosenberg; Daniel Rexroth
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

8.  Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease.

Authors:  Jing Liang; Héctor E López-Valdés; Hilda Martínez-Coria; A Kerstin Lindemeyer; Yi Shen; Xuesi M Shao; Richard W Olsen
Journal:  Neurochem Res       Date:  2014-04-13       Impact factor: 3.996

9.  Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.

Authors:  Hilda Martinez-Coria; Kim N Green; Lauren M Billings; Masashi Kitazawa; Miriam Albrecht; Gerhard Rammes; Chris G Parsons; Sandeep Gupta; Pradeep Banerjee; Frank M LaFerla
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 10.  Mild cognitive impairment: conceptual issues and structural and functional brain correlates.

Authors:  Andrew J Saykin; Heather A Wishart
Journal:  Semin Clin Neuropsychiatry       Date:  2003-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.